Skip to main content
SpringerLink
Log in

Role of Indian Herbal Medicine in the Treatment of Pulmonary Diseases

  • Chapter
  • First Online:
Medicinal Plants for Lung Diseases

  • 781 Accesses

Abstract

Pulmonary diseases such as asthma, chronic obstructive pulmonary disease, lung cancer, cystic fibrosis, pulmonary hypertension, pneumonia, pleurisy, sarcoidosis, and pulmonary embolism cause severe respiratory difficulties and can even be fatal without proper treatment. Although several chemical drugs are available for the treatment of pulmonary diseases, these drugs cause severe side effects and are not completely efficient. Herbal medicine is a suitable alternative with lesser side effects and can be used for the treatment of pulmonary diseases. Several herbal plants such as Allium sativum, Crataegus rhipidophylla, Moringa oleifera, Salvia miltiorrhiza, Terminalia arjuna, Withania somnifera can be used for the treatment of pulmonary diseases. Apple polyphenol, ligustrazine, salidroside, Resveratrol, quercetin are some examples of phytochemicals which exhibit characteristics with the potential to modulate the symptoms of pulmonary diseases. These herbal plants and phytochemicals undergo various mechanisms such as decreasing proliferation of epithelial cells, reducing oxidative stress, anti-inflammation, inhibiting proliferation of tumor cells, vasodilation, reducing bronchial constrictions, etc., to reduce the progression of pulmonary diseases. The different types of medicinal plants and phytochemicals which can be used to treat pulmonary diseases along with their mechanisms will be discussed in detail in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Donnelly JP, Baddley JW, Wang HE (2014) Antibiotic utilization for acute respiratory tract infections in U.S. emergency departments. Antimicrob Agents Chemother 58:1451–1457

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. WHO (2007) Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. https://www.who.int/gard/publications/GARD_Manual/en/. Accessed 30 Oct 2020

  3. WHO (2018) Cancer fact sheet. https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed 30 Oct 2020

  4. Hu Y, Sun J, Dai Z et al (2020) Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol 127:104371

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Petrovska BB (2012) Historical review of medicinal plants usage. Pharmacogn Rev 6:1–5

    Article  PubMed  PubMed Central  Google Scholar 

  6. Sofowora A, Ogunbodede E, Onayade A (2013) The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit Complement Altern Med 10:210–229

    PubMed  PubMed Central  Google Scholar 

  7. Farzaei F, Morovati MR, Farjadmand F et al (2017) A mechanistic review on medicinal plants used for diabetes mellitus in traditional persian medicine. J Evid Based Complement Altern Med 22:944–955

    Article  CAS  Google Scholar 

  8. Yuan H, Ma Q, Ye L et al (2016) The traditional medicine and modern medicine from natural products. Molecules 21:559

    Article  PubMed Central  CAS  Google Scholar 

  9. Ekor M (2014) The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 4:177

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. WHO (2019) WHO global report on traditional and complementary medicine 2019. https://www.who.int/traditional-complementary-integrative-medicine/. Accessed 30 Oct 2020

  11. Mathew L, Babu S (2011) Phytotherapy in India: transition of tradition to technology. Curr Bot 2:17–22

    Google Scholar 

  12. Dadoriya P, Dey YN, Sharma D et al (2020) In-vitro anti-inflammatory and antioxidant activities of an Ayurvedic formulation – Trayodashang guggulu. J Herb Med. https://doi.org/10.1016/j.hermed.2020.100366

  13. Tomar P, Dey YN, Sharma D et al (2018) Cytotoxic and antiproliferative activity of kanchnar guggulu, an Ayurvedic formulation. J Integr Med 16:411–417

    Article  PubMed  Google Scholar 

  14. Wanjari MM, Mishra S, Dey YN et al (2016) Antidiabetic activity of Chandraprabha vati - a classical Ayurvedic formulation. J Ayurveda Integr Med 7:144–150

    Article  PubMed  PubMed Central  Google Scholar 

  15. Liao SX, Sun PP, Gu YH et al (2019) Autophagy and pulmonary disease. Ther Adv Respir Dis 13:1753466619890538

    Article  PubMed  PubMed Central  Google Scholar 

  16. Rabe KF, Watz H (2017) Chronic obstructive pulmonary disease. Lancet 389:1931–1940

    Article  PubMed  Google Scholar 

  17. Manian P (2019) Chronic obstructive pulmonary disease classification, phenotypes and risk assessment. J Thorac Dis 11:S1761–S1766

    Article  PubMed  PubMed Central  Google Scholar 

  18. Mims JW (2015) Asthma: definitions and pathophysiology. Int Forum Allergy Rhinol 1:S2–S6

    Article  Google Scholar 

  19. Chung KF (2017) Clinical management of severe therapy-resistant asthma. Expert Rev Respir Med 11:395–402

    CAS  PubMed  Google Scholar 

  20. Wu TD, Brigham EP, McCormack MC (2019) Asthma in the primary care setting. Med Clin North Am 103:435–452

    Article  PubMed  PubMed Central  Google Scholar 

  21. Janssen R, Piscaer I, Franssen FME et al (2019) Emphysema: looking beyond alpha-1 antitrypsin deficiency. Expert Rev Respir Med 13:381–397

    Article  CAS  PubMed  Google Scholar 

  22. Kurashima K, Takaku Y, Ohta C et al (2017) Smoking history and emphysema in asthma-COPD overlap. Int J Chron Obstruct Pulmon Dis 12:3523–3532

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kim V, Criner GJ (2013) Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187:228–237

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Guillien A, Soumagne T, Dalphin JC et al (2019) COPD, airflow limitation and chronic bronchitis in farmers: a systematic review and meta-analysis. Occup Environ Med 76:58–68

    Article  PubMed  Google Scholar 

  25. Naeije R (2013) Physiology of the pulmonary circulation and the right heart. Curr Hypertens Rep 15:623–631

    Article  CAS  PubMed  Google Scholar 

  26. Vonk Noordegraaf A, Groeneveldt JA, Bogaard HJ (2016) Pulmonary hypertension. Eur Respir Rev 25:4–11

    Article  PubMed  Google Scholar 

  27. Humbert M, Montani D, Evgenov OV et al (2013) Definition and classification of pulmonary hypertension. Handb Exp Pharmacol 218:3–29

    Article  CAS  PubMed  Google Scholar 

  28. Essien EO, Rali P, Mathai SC (2019) Pulmonary embolism. Med Clin North Am 103:549–564

    Article  PubMed  Google Scholar 

  29. Ramiz S, Rajpurkar M (2018) Pulmonary embolism in children. Pediatr Clin N Am 65:495–507

    Article  Google Scholar 

  30. Fischer A, du Bois R (2012) Interstitial lung disease in connective tissue disorders. Lancet 380:689–698

    Article  PubMed  Google Scholar 

  31. Rafeeq MM, Murad HAS (2017) Cystic fibrosis: current therapeutic targets and future approaches. J Transl Med 15:84

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Paranjape SM, Mogayzel PJ Jr (2014) Cystic fibrosis. Pediatr Rev 35:194–205

    Article  PubMed  Google Scholar 

  33. Llanos O, Hamzeh N (2019) Sarcoidosis. Med Clin North Am 103:527–534

    Article  PubMed  Google Scholar 

  34. Soto-Gomez N, Peters JI, Nambiar AM (2016) Diagnosis and management of sarcoidosis. Am Fam Phys 93:840–848

    Google Scholar 

  35. Bargagli E, Prasse A (2018) Sarcoidosis: a review for the internist. Intern Emerg Med 13:325–331

    PubMed  Google Scholar 

  36. Ahn DG, Shin HJ, Kim MH et al (2020) Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol 30:313–324

    Article  PubMed  Google Scholar 

  37. Hani C, Trieu NH, Saab I et al (2020) COVID-19 pneumonia: a review of typical CT findings and differential diagnosis. Diagn Interv Imaging 101:263–268

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wang F, Nie J, Wang H et al (2020) Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis 221:1762–1769

    Article  CAS  PubMed  Google Scholar 

  39. Clarke R, Lundy FT, McGarvey L (2015) Herbal treatment in asthma and COPD – current evidence. Clin Phytosci 1:4

    Article  CAS  Google Scholar 

  40. Cesca TG, Faqueti LG, Rocha LW et al (2012) Antinociceptive, anti-inflammatory and wound healing features in animal models treated with a semisolid herbal medicine based on Aleurites moluccana L. Willd. Euforbiaceae standardized leaf extract: semisolid herbal. J Ethnopharmacol 143:355–362

    Article  CAS  PubMed  Google Scholar 

  41. Gholamnezhad Z, Shakeri F, Saadat S et al (2019) Clinical and experimental effects of Nigella sativa and its constituents on respiratory and allergic disorders. Avicenna J Phytomed 9:195–212

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Kumar D, Prasad D, Parkash J et al (2009) Antiasthmatic activity of ethanolic extract of Aerva lanata Linn. Pharmacologyonline 2:1075–1081

    Google Scholar 

  43. Samiulla DS, Prashanth D, Amit A (2001) Mast cell stabilising activity of Bacopa monnieri. Fitoterapia 72:284–285

    Article  CAS  PubMed  Google Scholar 

  44. Mali RG, Dhake AS (2011) Evaluation of effects of Bauhinia variegata stem bark extracts against milk-induced eosinophilia in mice. J Adv Pharm Technol Res 2:132–134

    Article  PubMed  PubMed Central  Google Scholar 

  45. Taur DJ, Patil RY (2011) Some medicinal plants with antiasthmatic potential: a current status. Asian Pac J Trop Biomed 1:413–418

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Ram A, Duraisamy A, Selvakumar B et al (2009) Medicinal plants from siddha system of medicine useful for treating respiratory diseases. Int J Pharm Anal 1:975–3079

    Google Scholar 

  47. Sharma PK, Johri S, Mehra BL (2010) Efficacy of Vasadi syrup and Shwasaghna Dhuma in the patients of COPD (Shwasa Roga). Ayu 31:48–52

    Article  PubMed  PubMed Central  Google Scholar 

  48. Prakash P, Gupta N (2005) Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review. Indian J Physiol Pharmacol 49:125–131

    CAS  PubMed  Google Scholar 

  49. Gruenwald J, Graubaum H-J, Busch R (2005) Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis. A double-blind, randomized, placebo-controlled clinical trial. Arzneimittelforschung 55:669–676

    CAS  PubMed  Google Scholar 

  50. Guo R, Pittler MH, Ernst E (2006) Herbal medicines for the treatment of COPD: a systematic review. Eur Respir J 28:330–338

    Article  CAS  PubMed  Google Scholar 

  51. Wienkötter N, Höpner D, Schütte U et al (2008) The effect of nigellone and thymoquinone on inhibiting trachea contraction and mucociliary clearance. Planta Med 74:105–108

    Article  PubMed  CAS  Google Scholar 

  52. Suzuki M, Betsuyaku T, Ito Y et al (2009) Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice. Am J Physiol Lung Cell Mol Physiol 296:L614–L623

    Article  CAS  PubMed  Google Scholar 

  53. Sartor L, Pezzato E, Garbisa S (2002) (−)Epigallocatechin-3-gallate inhibits leukocyte elastase: potential of the phyto-factor in hindering inflammation, emphysema, and invasion. J Leukoc Biol 71:73–79

    Article  CAS  PubMed  Google Scholar 

  54. Ganesan S, Faris AN, Comstock AT et al (2010) Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression. Respir Res 11:131

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Mohammad P, Nosratollah Z, Mohammad R et al (2010) The inhibitory effect of Curcuma longa extract on telomerase activity in A549 lung cancer cell line. Afr J Biotechnol 9:912–919

    Article  CAS  Google Scholar 

  56. Kooti W, Servatyari K, Behzadifar M et al (2017) Effective medicinal plant in cancer treatment, part 2: review study. J Evid Based Complement Altern Med 22:982–995

    Article  CAS  Google Scholar 

  57. Valiahdi SM, Iranshahi M, Sahebkar A (2013) Cytotoxic activities of phytochemicals from Ferula species. Daru 21:39

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Desai AG, Qazi GN, Ganju RK et al (2008) Medicinal plants and cancer chemoprevention. Curr Drug Metab 9:581–591

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Singh RP, Banerjee S, Rao AR (2001) Modulatory influence of Andrographis paniculata on mouse hepatic and extrahepatic carcinogen metabolizing enzymes and antioxidant status. Phytother Res 15:382–390

    Article  CAS  PubMed  Google Scholar 

  60. Huang S-T, Yang R-C, Lee P-N et al (2006) Anti-tumor and anti-angiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma. Int Immunopharmacol 6:870–879

    Article  CAS  PubMed  Google Scholar 

  61. Garodia P, Ichikawa H, Malani N et al (2007) From ancient medicine to modern medicine: ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integr Oncol 5:25–37

    Article  PubMed  Google Scholar 

  62. Sousa M, Ousingsawat J, Seitz R et al (2007) An extract from the medicinal plant Phyllanthus acidus and its isolated compounds induce airway chloride secretion: a potential treatment for cystic fibrosis. Mol Pharmacol 71:366–376

    Article  CAS  PubMed  Google Scholar 

  63. Dey I, Shah K, Bradbury NA (2016) Natural compounds as therapeutic agents in the treatment cystic fibrosis. J Genet Syndr Gene Ther 7:284

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Hwang TC, Wang F, Yang IC et al (1997) Genistein potentiates wild-type and delta F508-CFTR channel activity. Am J Phys 273:C988–C998

    Article  CAS  Google Scholar 

  65. Sumbilla C, Lewis D, Hammerschmidt T et al (2002) The slippage of the Ca2+ pump and its control by anions and curcumin in skeletal and cardiac sarcoplasmic reticulum. J Biol Chem 277:13900–13906. https://doi.org/10.1074/jbc.M111155200

    Article  CAS  PubMed  Google Scholar 

  66. El-Mowafy AM, Alkhalaf M (2003) Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis 24:869–873

    Article  CAS  PubMed  Google Scholar 

  67. Bombicz M, Priksz D, Varga B et al (2017) A novel therapeutic approach in the treatment of pulmonary arterial hypertension: allium ursinum liophylisate alleviates symptoms comparably to sildenafil. Int J Mol Sci 18:1436

    Article  PubMed Central  CAS  Google Scholar 

  68. Ahmadipour B, Kalantar M, Hosseini SM et al (2017) Hawthorn (Crataegus Oxyacantha) extract in the drinking water of broilers on growth and incidence of pulmonary hypertension syndrome (PHS). Rev Bras Cienc Avic 19:639–644

    Article  Google Scholar 

  69. Chen K-H, Chen Y-J, Yang C-H et al (2012) Attenuation of the extract from Moringa oleifera on monocrotaline-induced pulmonary hypertension in rats. Chin J Physiol 55:22–30

    Article  CAS  PubMed  Google Scholar 

  70. Gupta VK, Kaushik A, Chauhan DS et al (2018) Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms. J Ethnopharmacol 227:113–120

    Article  PubMed  Google Scholar 

  71. Hussain Z, Muhammad P, Sadozai S et al (2011) Extraction of anti-pneumonia fractions from the leaves of sugar beets Beta vulgaris. J Pharm Res 4:4783–4785

    Google Scholar 

  72. Asadbeigi M, Mohammadi T, Rafieian-Kopaei M et al (2014) Traditional effects of medicinal plants in the treatment of respiratory diseases and disorders: an ethnobotanical study in the Urmia. Asian Pac J Trop Med 7S1:S364–S368

    Article  PubMed  Google Scholar 

  73. Ranasinghe P, Pigera S, Premakumara GS et al (2013) Medicinal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): a systematic review. BMC Complement Altern Med 13:275

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  74. Desai TH, Joshi SV (2019) Anticancer activity of saponin isolated from Albizia lebbeck using various in vitro models. J Ethnopharmacol 231:494–502

    Article  CAS  PubMed  Google Scholar 

  75. Singh B, Sharma RA (2013) Anti-inflammatory and antimicrobial properties of pyrroloquinazoline alkaloids from Adhatoda vasica Nees. Phytomedicine 20:441–445. https://doi.org/10.1016/j.phymed.2012.12.015

    Article  CAS  PubMed  Google Scholar 

  76. Sharafkhaneh A, Velamuri S, Badmaev V et al (2007) The potential role of natural agents in treatment of airway inflammation. Ther Adv Respir Dis 1:105–120

    Article  PubMed  Google Scholar 

  77. Patel JJ, Acharya SR, Acharya NS (2014) Clerodendrum serratum (L.) moon. - a review on traditional uses, phytochemistry and pharmacological activities. J Ethnopharmacol 154:268–285

    Article  CAS  PubMed  Google Scholar 

  78. Benarba B, Pandiella A (2020) Medicinal plants as sources of active molecules against COVID-19. Front Pharmacol 11:1189

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Bhuiyan FR, Howlader S, Raihan T et al (2020) Plants metabolites: possibility of natural therapeutics against the COVID-19 pandemic. Front Med 7:444

    Article  Google Scholar 

  80. Adhikari B, Marasini BP, Rayamajhee B et al (2020) Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: a review. Phytother Res. https://doi.org/10.1002/ptr.6893

  81. Girija PLT, Sivan N (2020) Ayurvedic treatment of COVID-19/SARS-CoV-2: a case report. J Ayurveda Integr Med. https://doi.org/10.1016/j.jaim.2020.06.001

  82. Parasuraman S, Thing GS, Dhanaraj SA (2014) Polyherbal formulation: concept of ayurveda. Pharmacogn Rev 8:73–80

    Article  PubMed  PubMed Central  Google Scholar 

  83. Radomska-Leśniewska DM, Skopińska-Różewska E, Demkow U et al (2016) A natural herbal remedy modulates angiogenic activity of bronchoalveolar lavage cells from sarcoidosis patients. Cent Eur J Immunol 41:25–34

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  84. Mahmud S, Akhter S, Rahman MA et al (2015) Antithrombotic effects of five organic extracts of bangladeshi plants in vitro and mechanisms in in silico models. Evid Based Complement Alternat Med:782742

    Google Scholar 

  85. Ansari V, Siddiqui H, Singh SP (2012) Antithrombotic and thrombolytic activity of terminalia belerica fruit extracts. Res J Pharm Biol Chem Sci 3:471–478

    Google Scholar 

  86. Gogoi D, Arora N, Kalita B et al (2018) Anticoagulant mechanism, pharmacological activity, and assessment of preclinical safety of a novel fibrin(ogen)olytic serine protease from leaves of Leucas indica. Sci Rep 8:6210

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  87. Bijak M, Sut A, Kosiorek A et al (2019) Dual anticoagulant/antiplatelet activity of polyphenolic grape seeds extract. Nutrients 11:93

    Article  CAS  PubMed Central  Google Scholar 

  88. Chourasia SR, Kashyap RS, Deopujari JY et al (2014) Effect of aqueous extract and fractions of Fagonia arabica on in vitro anticoagulant activity. Clin Appl Thromb Hemost 20:844–850

    Article  PubMed  Google Scholar 

  89. Gholkar AA, Nikam YP, Zambare KK et al (2020) Potential anticoagulant herbal plants: a review. Asian J Res Pharm Sci 10:51–55

    Google Scholar 

  90. Ram A, Balachandar S, Vijayananth P et al (2011) Medicinal plants useful for treating chronic obstructive pulmonary disease (COPD): current status and future perspectives. Fitoterapia 82:141–151

    Article  PubMed  Google Scholar 

  91. de Monteiro LS, Bastos KX, Barbosa-Filho JM et al (2014) Medicinal plants and other living organisms with antitumor potential against lung cancer. Evid Based Complement Alternat Med:604152

    Google Scholar 

  92. Adnan M, Ali S, Sheikh K et al (2019) Review on antibacterial activity of Himalayan medicinal plants traditionally used to treat pneumonia and tuberculosis. J Pharm Pharmacol 71:1599–1625

    Article  CAS  PubMed  Google Scholar 

  93. Jasemi SV, Khazaei H, Aneva IY et al (2020) Medicinal plants and phytochemicals for the treatment of pulmonary hypertension. Front Pharmacol 11:145

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biotechnology, Anna University, Chennai, Tamil Nadu, India

    M. Ovia

  2. Department of Biotechnology, Sri Venkateswara College of Engineering (Autonomous – Affiliated to Anna University), Sriperumbudur, Tamil Nadu, India

    M. Yasasve

  3. Department of Biotechnology, Sree Sastha Institute of Engineering and Technology (Affiliated to Anna University), Chennai, Tamil Nadu, India

    L. Ansel Vishal

Authors
  1. M. Ovia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Yasasve
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Ansel Vishal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Ansel Vishal .

Editor information

Editors and Affiliations

  1. Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia

    Kamal Dua

  2. Discipline of Medical Sciences, School of Science, Western Sydney University, Sydney, NSW, Australia

    Srinivas Nammi

  3. NICM Health Research Institute, Western Sydney University, Sydney, NSW, Australia

    Dennis Chang

  4. Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia

    Dinesh Kumar Chellappan

  5. School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India

    Gaurav Gupta

  6. Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia

    Trudi Collet

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ovia, M., Yasasve, M., Ansel Vishal, L. (2021). Role of Indian Herbal Medicine in the Treatment of Pulmonary Diseases. In: Dua, K., Nammi, S., Chang, D., Chellappan, D.K., Gupta, G., Collet, T. (eds) Medicinal Plants for Lung Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-33-6850-7_3

Download citation

Publish with us

Policies and ethics

Search

Navigation